CN109453089B - Delicate repair eye cream and preparation method thereof - Google Patents

Delicate repair eye cream and preparation method thereof Download PDF

Info

Publication number
CN109453089B
CN109453089B CN201811633506.0A CN201811633506A CN109453089B CN 109453089 B CN109453089 B CN 109453089B CN 201811633506 A CN201811633506 A CN 201811633506A CN 109453089 B CN109453089 B CN 109453089B
Authority
CN
China
Prior art keywords
portions
parts
phase
eye cream
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811633506.0A
Other languages
Chinese (zh)
Other versions
CN109453089A (en
Inventor
吕飞
王华英
黄刚
汪华斌
沈鸿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201811633506.0A priority Critical patent/CN109453089B/en
Publication of CN109453089A publication Critical patent/CN109453089A/en
Application granted granted Critical
Publication of CN109453089B publication Critical patent/CN109453089B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8135Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88Polyamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9711Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The delicate repairing eye cream comprises the following components in parts by mass: polydimethylsiloxane, polymethylsilsesquioxane, phytosterol oleate, tocopheryl acetate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, carbomer, PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether, inulin lauryl carbamate, polyglutamic acid, cyclopolydimethylsiloxane/dimethiconol mixture, triethanolamine, caffeine, glucosyl hesperidin, bitter orange flower extract, inositol, oat glucan, undaria pinnatifida extract, immediate wrinkle removal essence, starfish rejuvenation supplement, centella asiatica extract, centella asiatica polypeptide, yeast bifida fermentation product lysate, anti-allergic active peptide, phenoxyethanol, and menthone. The texture is fresh and cool and is not greasy, and 7 major problems of skin around eyes can be effectively improved: fine lines, wrinkles, laxity, under-eye puffiness, dark under-eye circles, dryness.

Description

Delicate repair eye cream and preparation method thereof
Technical Field
The invention relates to a skin care product, in particular to delicate repair eye cream and a preparation method thereof.
Background
The pouch is medically known as lower eyelid skin sagging. The eyelid is characterized in that the skin of the lower eyelid is loose due to the aging, the connection between the skin and the fibrous tissue between the orbicularis oculi is weakened, meanwhile, the fat tissue under the orbit diaphragm and in the eye protrudes outwards through the weak part of the orbit diaphragm, and the eyelid is formed into a puffy bag-shaped structure under the skin, so the eyelid is called as an eye bag. The pouch is a physiological change in normal persons.
With the increase of age, the work rest time is irregular, the metabolism of eye skin slows down, collagen and elastic fiber begin to slowly run off, the fat of nursing eyeball begins slowly to silt up, and finally, the pouch has just been produced.
The etiology of pouch formation: 1) the etiology of aging and degeneration is as follows: (1) the elasticity of the skin of the lower eyelid is weakened, relaxed and drooped; (2) retrogressive change of the orbicularis muscle of the lower eyelid, elasticity weakening, relaxation and atrophy; (3) the orbital diaphragm is denatured and relaxed, and the supporting force is weakened; (4) orbital steatosis, displacement or orbital steatosis. 2) The genetic etiology: some young people also have lower eyelid pouch, which is mostly related to family genetic factors.
The hereditary pouch is not effective with conservative therapy and can only be corrected by surgery. The bags in the eyes of most people are acquired. The eyelid bag shaping method comprises two methods, namely, an eyelid conjunctiva approach (inner incision) and a skin approach (outer incision), the inner incision eye bag shaping method is suitable for people with low eyelid skin elasticity and orbit septal fat protrusion, an incision with the length of about 0.5CM is made in the eyelid conjunctiva, redundant fat is removed, the operation wound is small, the recovery is fast, and no operation trace exists. The external incision eye bag can simultaneously remove loose skin, hypertrophic orbicularis oculi muscle and redundant intraorbital fat, is suitable for various eye bag plastic, and has better operation effect.
Classification of pouches: 1) simple skin relaxation type: the main manifestations of simple skin relaxation and wrinkle increase are no orbital septal fat protrusion and orbicularis oculi muscle hypertrophy; 2) simple orbicularis oculi muscle is hypertrophic: the symptoms are that the orbicularis oculi muscle is fat and swollen on the lower eyelid, the skin is not loose, and the symptoms are more than that of young people; 3) orbital septal fat hernia type: the fat of the orbital septum is not obviously increased, but the tissues outside the orbital septum are loose and the tension is reduced, so that the orbital septum fat is herniated; 4) orbital septal fat increase mainly manifested by increased orbital septal fat tissue, and the relaxation of skin and orbicularis oculi muscle, which forms obvious sagging in the lower eyelid; 5) mixing: most of the palpebral sacs include weak and loose skin and orbicularis oculi muscle, weak orbital septum, and swelling of orbital fat, which are common in the middle-aged and the elderly.
Because the pouch plastic surgery has certain risk, even if the plastic surgery is finished, the later nursing is consolidated by eye cream nursing. The invention has effects on the first and second type of pouch, improves the latter three types of pouch, and has effects on pouch postoperative care.
Therefore, there is a need to develop a repair eye cream to improve 7 big problems of the skin around the eyes: fine lines, wrinkles, laxity, under-eye puffiness, dark under-eye circles, dryness.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provide the delicate repairing eye cream which is light and moist in texture, can refresh the skin after being used, enhances the free radical resisting capability, smoothes wrinkles, shines glowing, restores elasticity, and has the advantages of moistening, fine and compact skin and the preparation method thereof.
The purpose of the invention is realized by the following technical scheme:
the delicate repair eye cream comprises the following components in parts by mass:
phase A: 0.05 to 0.8 portion of polyglycerol-10 stearate, 0.5 to 5.0 portions of polydimethylsiloxane, 0.05 to 2.0 portions of polymethylsilsesquioxane, 0.5 to 5.0 portions of hydrogenated coconut oil glyceride, 0.05 to 2.0 portions of phytosterol oleate and 0.05 to 2.0 portions of tocopheryl acetate;
phase B: 50.0 to 100.0 portions of deionized water, 1.0 to 11.0 portions of glycerol, 0.1 to 0.8 portion of hydrogenated lecithin, 0.1 to 1.0 portion of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2 to 0.6 portion of carbomer, 0.1 to 0.8 portion of PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether and 0.1 to 1.0 portion of inulin lauryl carbamate;
and C phase: 0.01 to 0.5 portion of polyglutamic acid and 0.1 to 2.0 portions of cyclomethicone/dimethiconol mixture;
phase D: 0.15 to 0.55 portion of triethanolamine;
phase E: 0.5 to 5.0 portions of caffeine, 0.1 to 2.0 portions of glucosyl hesperidin, 0.0 to 5.0 portions of bitter orange flower extract, 0.5 to 10.0 portions of inositol, 0.5 to 5.0 portions of oat glucan, 0.0 to 4.0 portions of undaria pinnatifida extract, 0.0 to 3.0 portions of instant wrinkle removing essence, 0.1 to 3.0 portions of Starfish regeneration repair factor, 0.1 to 3.0 portions of centella asiatica extract, 0.1 to 3.0 portions of centella asiatica polypeptide, 0.1 to 3.0 portions of yeast bifida fermentation lysate and 0.1 to 1.5 portions of anti-allergy active peptide;
and (3) phase F: 0.2 to 0.8 portion of phenoxyethanol, 0.1 to 0.5 portion of fragrant fresh ketone and 0.01 to 0.1 portion of essence.
The delicate repair eye cream of another embodiment comprises the following components in parts by mass:
phase A: 0.1 to 0.6 portion of polyglycerol-10 stearate, 1.0 to 4.0 portions of polydimethylsiloxane, 0.1 to 1.0 portion of polymethylsilsesquioxane, 0.8 to 4.0 portions of hydrogenated coconut oil glyceride, 0.15 to 1.8 portions of phytosterol oleate and 0.2 to 1.7 portions of tocopheryl acetate;
phase B: 52.0 to 90.0 portions of deionized water, 3.0 to 11.0 portions of glycerol, 0.2 to 0.6 portion of hydrogenated lecithin, 0.4 to 1.0 portion of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2 to 0.5 portion of carbomer, 0.3 to 0.7 portion of PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether and 0.2 to 0.8 portion of inulin lauryl carbamate;
and C phase: 0.05 to 0.3 portion of polyglutamic acid and 0.2 to 1.0 portion of cyclomethicone/dimethiconol mixture;
phase D: 0.16 to 0.35 portion of triethanolamine;
phase E: 1.5 to 3.0 parts of caffeine, 0.2 to 1.7 parts of glucosyl hesperidin, 1.0 to 4.0 parts of bitter orange flower extract, 2.5 to 7.0 parts of inositol, 1.5 to 4.0 parts of oat glucan, 1.2 to 3.0 parts of undaria pinnatifida extract, 0.6 to 2.0 parts of instant wrinkle removing essence, 1.1 to 2.0 parts of Starfish regeneration and repair factor, 0.8 to 2.0 parts of centella asiatica extract, 0.4 to 2.0 parts of centella asiatica polypeptide, 0.4 to 2.5 parts of yeast bifida fermentation lysate and 0.3 to 1.1 parts of anti-allergy active peptide;
and (3) phase F: 0.3 to 0.6 portion of phenoxyethanol, 0.1 to 0.4 portion of fragrant fresh ketone and 0.01 to 0.07 portion of essence.
The delicate repair eye cream of another embodiment comprises the following components in parts by mass:
phase A: 0.3 part of polyglycerol-10 stearate, 2.0 parts of polydimethylsiloxane, 0.5 part of polymethylsilsesquioxane, 3.0 parts of hydrogenated coconut oil glycerides, 0.5 part of phytosterol oleate and 0.5 part of tocopherol acetate;
phase B: 58.84 parts of deionized water, 10 parts of glycerol, 0.3 part of hydrogenated lecithin, 0.8 part of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.3 part of carbomer, 0.5 part of PEG-240/HDI copolymer bis-decyltetradecylpolyether-20 ether and 0.3 part of inulin lauryl carbamate;
and C phase: 0.1 part of polyglutamic acid, and 0.5 part of cyclomethicone/dimethiconol mixture;
phase D: 0.25 part of triethanolamine;
phase E: 2.0 parts of caffeine, 0.5 part of glucosyl hesperidin, 2.0 parts of bitter orange flower extract, 5.0 parts of inositol, 2.0 parts of oat glucan, 2.0 parts of undaria pinnatifida extract, 1.0 part of instant wrinkle removal essence, 1.6 parts of starfish regeneration and repair factor, 1.0 part of centella asiatica extract, 1.0 part of centella asiatica polypeptide, 2.0 parts of yeast schizolysis product and 0.5 part of anti-allergy active peptide;
and (3) phase F: 0.5 part of phenoxyethanol, 0.2 part of fragrant fresh ketone and 0.01 part of essence.
In one embodiment, the centella asiatica extract is asiaticoside, madecassoside, asiatic acid, and madecassic acid.
In one embodiment, the instant wrinkle-removing essence is alteromonas ferment product extract.
A method of preparing an delicate repair eye cream of an embodiment includes the steps of:
cleaning and sterilizing equipment for later use;
adding polyglycerol-10 stearate, polydimethylsiloxane, polymethylsilsesquioxane and hydrogenated coconut oil glyceride into an oil phase pot, carrying out first heating and stirring operation, keeping constant temperature until the materials are completely dissolved, then adding phytosterol oleate and tocopherol acetate, and uniformly mixing to obtain an oil phase mixture, wherein the mass ratio of the polyglycerol-10 stearate to the polydimethylsiloxane to the polymethylsilsesquioxane to the hydrogenated coconut oil glyceride to the phytosterol oleate to the tocopherol acetate is (0.05-0.8): (0.5-5.0): (0.05-2.0): (0.5-5.0): (0.05-2.0): (0.05-2.0);
adding deionized water, glycerol, hydrogenated lecithin, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, carbomer, PEG-240/HDI copolymer bis-decyltetradecyltetradecylpolyether-20 ether and inulin lauryl carbamate into an emulsifying pot, carrying out second heating and stirring operation, keeping the constant temperature for 9-12 minutes, carrying out first homogenization operation, adding a mixture of polyglutamic acid and cyclopolydimethylsiloxane/dimethiconol and the oil phase mixture, stirring, carrying out second homogenization operation under a vacuum condition, then carrying out defoaming operation, adding triethanolamine and uniformly stirring, wherein the deionized water, the glycerol, the hydrogenated lecithin, the hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, the carbomer, the PEG-240/HDI copolymer bis-decyltetradecyltetradecyltetradecyltetradecyltetradecyltetradecyltolyether-20 ether, the carbomer, the PEG-240/HDI copolymer, the inulin lauryl taurate copolymer, the ethylene glycol and the HDI copolymer, The inulin lauryl carbamate, the polyglutamic acid, the cyclopolydimethylsiloxane/dimethiconol mixture, the oil phase mixture and the triethanolamine are in a mass ratio of (50.0-100.0): (1.0-11.0): (0.1-0.8): (0.1-1.0): (0.2-0.6): (0.1-0.8): (0.1-1.0): (0.01-0.5): (0.1-2.0): (1.2-16.8): (0.15 to 0.55);
after the first cooling operation is carried out, sequentially adding caffeine, glucosyl hesperidin, a bitter orange flower extract, inositol, oat glucan, an undaria pinnatifida extract, instant wrinkle removing essence, a starfish regeneration repair factor, an centella asiatica extract, centella asiatica polypeptide, a schizosaccharomyces cerevisiae fermentation product lysate and an anti-allergy active peptide, carrying out a third stirring operation, and keeping at a constant temperature until the materials are completely dissolved, wherein the caffeine, the glucosyl hesperidin, the bitter orange flower extract, the inositol, the oat glucan, the undaria pinnatifida extract, the instant wrinkle removing essence, the starfish regeneration repair factor, the centella asiatica extract, the centella asiatica polypeptide, the schizosaccharomyces cerevisiae fermentation product lysate and the anti-allergy active peptide are mixed according to a mass ratio of (0.5-5.0): (0.1-2.0): (0.0-5.0): (0.5-10.0): (0.5-5.0): (0.0-4.0): (0.0-3.0): (0.1-3.0): (0.1-3.0): (0.1-3.0): (0.1-3.0): (0.1 to 1.5);
after the second cooling operation is carried out, sequentially adding the pre-dissolved phenoxyethanol, the pre-dissolved menthone and the essence, and uniformly stirring to obtain a repair eye cream precursor;
and after the third cooling operation is carried out, the repairing eye cream precursor is subjected to detection operation, and filtered and discharged after being qualified, so that the delicate repairing eye cream is obtained.
In one embodiment, the temperature of the first heating and stirring operation is 70 ℃ to 75 ℃.
In one embodiment, the temperature of the second heating and stirring operation is 80 ℃ to 85 ℃.
In one embodiment, after the second temperature reduction operation, the temperature is controlled to be 42-44 ℃.
In one embodiment, after the third temperature reduction operation, the temperature is controlled to be 38 ℃ to 39 ℃.
The delicate repair eye cream comprises the following components in parts by mass: polydimethylsiloxane, polymethylsilsesquioxane, phytosterol oleate, tocopheryl acetate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, carbomer, PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether, inulin lauryl carbamate, polyglutamic acid, cyclopolydimethylsiloxane/dimethiconol mixture, triethanolamine, caffeine, glucosyl hesperidin, bitter orange flower extract, inositol, oat glucan, undaria pinnatifida extract, immediate wrinkle removal essence, starfish rejuvenation supplement, centella asiatica extract, centella asiatica polypeptide, yeast bifida fermentation product lysate, anti-allergic active peptide, phenoxyethanol, and menthone. The texture is fresh and cool and is not greasy, and 7 major problems of skin around eyes can be effectively improved: fine lines, wrinkles, laxity, under-eye puffiness, dark under-eye circles, dryness.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings needed to be used in the embodiments will be briefly described below, it should be understood that the following drawings only illustrate some embodiments of the present invention and therefore should not be considered as limiting the scope, and for those skilled in the art, other related drawings can be obtained according to the drawings without inventive efforts.
Fig. 1 is a flowchart illustrating steps of a method for preparing a delicate repair eye cream according to an embodiment of the present invention;
fig. 2 is a schematic step view of a method for using the delicate repair eye cream according to an embodiment of the present invention.
Detailed Description
To facilitate an understanding of the invention, the invention will now be described more fully with reference to the accompanying drawings. Preferred embodiments of the present invention are shown in the drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete.
It will be understood that when an element is referred to as being "secured to" another element, it can be directly on the other element or intervening elements may also be present. When an element is referred to as being "connected" to another element, it can be directly connected to the other element or intervening elements may also be present. The terms "vertical," "horizontal," "left," "right," and the like as used herein are for illustrative purposes only and do not represent the only embodiments.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used herein in the description of the invention is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
In one embodiment, the delicate repair eye cream comprises the following components in parts by mass:
phase A: 0.05 to 0.8 portion of polyglycerol-10 stearate, 0.5 to 5.0 portions of polydimethylsiloxane, 0.05 to 2.0 portions of polymethylsilsesquioxane, 0.5 to 5.0 portions of hydrogenated coconut oil glyceride, 0.05 to 2.0 portions of phytosterol oleate and 0.05 to 2.0 portions of tocopheryl acetate;
phase B: 50.0 to 100.0 portions of deionized water, 1.0 to 11.0 portions of glycerol, 0.1 to 0.8 portion of hydrogenated lecithin, 0.1 to 1.0 portion of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2 to 0.6 portion of carbomer, 0.1 to 0.8 portion of PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether and 0.1 to 1.0 portion of inulin lauryl carbamate;
and C phase: 0.01 to 0.5 portion of polyglutamic acid and 0.1 to 2.0 portions of cyclomethicone/dimethiconol mixture;
phase D: 0.15 to 0.55 portion of triethanolamine;
phase E: 0.5 to 5.0 portions of caffeine, 0.1 to 2.0 portions of glucosyl hesperidin, 0.0 to 5.0 portions of bitter orange flower extract, 0.5 to 10.0 portions of inositol, 0.5 to 5.0 portions of oat glucan, 0.0 to 4.0 portions of undaria pinnatifida extract, 0.0 to 3.0 portions of instant wrinkle removing essence, 0.1 to 3.0 portions of Starfish regeneration repair factor, 0.1 to 3.0 portions of centella asiatica extract, 0.1 to 3.0 portions of centella asiatica polypeptide, 0.1 to 3.0 portions of yeast bifida fermentation lysate and 0.1 to 1.5 portions of anti-allergy active peptide;
and (3) phase F: 0.2 to 0.8 portion of phenoxyethanol, 0.1 to 0.5 portion of fragrant fresh ketone and 0.01 to 0.1 portion of essence.
It can be understood that polyglycerol-10 stearate (Polyaldo 10-1-S), also known as decaglycerol monostearate, is a good dispersant, stabilizer and protectant, and can make the fine repair eye cream have better quality such as stability, further, the manufacturer of polyglycerol-10 stearate is a dragon sand group, so that the adoption of polyglycerol-10 stearate is beneficial to improving the stability of the fine repair eye cream. Polydimethylsiloxane (DC200) is used as a base oil component, is light, fresh and non-greasy in texture, can improve the formula and touch, has no long-term residue, and is an ideal raw material commonly used in a cosmetic formula. The polymethylsilsesquioxane is spherical organic silicon resin, the diameter of the micro particles is 4-6 microns, the spreadability of the skin care product can be improved, and the ductility and smoothness of the delicate repair eye cream can be enhanced. The hydrogenated coconut oil glyceride is triglyceryl of C10-C18 saturated vegetable fatty acid, is used as antioxidant hard fat in the exquisite repair eye cream, is similar to the skin structure, is odorless and non-sticky, gives the skin luster and high-quality skin feel, can improve the ability of resisting free radicals of the exquisite repair eye cream, and makes the skin moist and bright after use. The phytosterol oleate is generally prepared by esterification reaction or transesterification reaction of phytosterol and fatty acid, and is used as a conditioner and a softening agent in the delicate eye cream. The sitosterol has stronger anti-inflammatory action similar to hydrocortisone, oxyphenbutazone and the like, but has no side effect of cortisones; there is also a role in the repair of skin barrier function: the intercellular liposomes are ceramide, cholesterol and fatty acid in a ratio of 1: 1: 1 mol ratio, the phytosterol ester and the cholesterol have similar structures, can replace the cholesterol, and has the effect of repairing the skin barrier function. The tocopherol acetate is used as an antioxidant in the delicate repair eye cream, has a good antioxidant effect, and has the effects of preventing cell membranes, unsaturated fatty acids and other easily-oxidized substances in cells from being oxidized and preventing aging in the metabolism process of a body; also can be used as antioxidant in vivo, to eliminate free radicals in vivo, and reduce the damage of ultraviolet rays to human body. Therefore, the components in the phase A can effectively improve the light and moist texture of the delicate repair eye cream, and after the repair eye cream is used, the capability of resisting free radicals of eye skin can be enhanced, fine lines and wrinkles can be smoothed, looseness, pouches and edema can be relieved, dark eye circles can be lightened, and the problem of dryness can be solved.
It is understood that the use of deionized water as a solvent further improves the purity of the delicate repair eye cream. The glycerin is a common humectant, the hydrogenated lecithin is a stable emulsifier and humectant formed by the hydrogenation of lecithin under the action of a catalyst, and can improve the moisturizing performance of the delicate repair eye cream and promote the emulsification. Hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (EMT 15) was used as an emulsifier, thickener, viscosity modifier in the fine conditioning eye cream, and further, the manufacturer of the hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer was SNF company of France. Carbomer has a highly effective thickening effect, produces a clear and transparent hydrogel body, has very short rheological properties, and enables the delicate repair eye cream to more easily penetrate the skin and promote absorption. PEG-240/HDI copolymer bis-decyl tetradecyl polyether-20 ether (ADEKA Nol GT-730) is a nonionic emulsion stable thickener, does not need neutralization, has good film forming property, and can form smooth skin feeling like hyaluronic acid on skin; high electrolyte resistance; high temperature resistance, heating resistance and high viscosity, and can be stably homogenized; the delicate repair eye cream has the characteristics of extremely sensitive shear thinning, excellent thixotropy and quick recovery, so that the rheological property and the stability of the delicate repair eye cream can be greatly improved. Further, the manufacturer of the PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether was the company ADEKA, Japan. Inulin lauryl carbamate (INUTEC SL1) is used as an emulsion stabilizer and dispersant in the fine conditioning eye cream, enabling great stability and uniformity of the fine conditioning eye cream. Further, the producer of inulin lauryl carbamate is the vetting company, france. Thus, the use of the components of phase B can improve the emulsifying properties of the fine repair eye cream, improve the stability and dispersing properties, and also improve the moisturizing properties and rheological properties, and has a pleasant skin feel and a low slimy feel.
It can be understood that polyglutamic acid, also known as bacillus natto glue and polyglutamic acid, is a biological polymer which is water-soluble, biodegradable, non-toxic and prepared by a microbial fermentation method. Has good moisturizing performance, and can improve the moisturizing performance of the delicate repairing eye cream. The cyclomethicone/dimethiconol mixture (DC1403) was a 13% strength solution of ultra high viscosity dimethiconol in volatile cyclomethicone, enabling the mousse cream to have a soft smooth skin feel, reduced slimy feel, and further the manufacturer of the cyclomethicone/dimethiconol mixture was dow corning corporation, usa. Thus, the adoption of the components of the phase C can improve the moisturizing performance and the absorption performance of the delicate repair eye cream, and enhance the performance of the eye skin barrier and the elasticity recovery.
Particularly, caffeine can decompose triglyceride in fat cells into fatty acid and glycerol, reduce ocular edema and excessive accumulation of intercellular fluid due to inflammation of cellulite, stimulate microcirculation and metabolism, accelerate local microcirculation, and make the delicate repair eye cream effective in relieving problems of relaxation, pouch and edema. Glucosyl hesperidin can protect and repair capillary vessels, reduce blood leakage and inflammation diffusion, improve vasodilatation, promote microcirculation and nutrition supplement, promote fat metabolism, improve the repair performance of the delicate repair eye cream, and effectively improve the problems of fine lines, wrinkles, looseness, pouches, edema, dark circles and dryness of skin around eyes. The neroli extract (Remoduline) is rich in methoxyflavonoids and flavanones and is capable of decomposing fats: the triglyceride in the fat cells is decomposed into fatty acid and glycerol, and the vasodilation and the microcirculation are improved, so that the fat in the skin tissue is promoted to be discharged, and the problems of relaxation, pouch and edema of the delicate repair eye cream are solved. Further, the manufacturer of the neroli extract is SILAB, france. Inositol can adjust cell osmotic pressure, maintain oil-water balance of keratinocytes, stimulate dermal stem cells, and fibroblasts differentiated from the dermal stem cells can generate dermal components such as collagen, elastin and hyaluronic acid, so that the skin can be substantially improved, and the moisturizing effect is increased. Oat glucan has good moisturizing and antiallergic effects, can inhibit mast cells from releasing histamine, relieve anaphylaxis, promote wound healing and macrophage proliferation, release various cytokines such as EGF and AF, and improve the anti-aging and anti-free radical properties of the delicate eye cream and the collagen and fibroblast proliferation promoting properties. The undaria pinnatifida extract can reactivate 14 genes related to synthesis, maturation, aggregation and linkage of elastin, collagen and hyaluronic acid, has remarkable repairing and tightening effects, recovers skin vitality, enables the skin to be younger, can improve the tightening and tightening effects of the delicate repair eye cream, and is beneficial to improving the skin problem around eyes. The instant wrinkle removal essence can greatly improve the wrinkle smoothing performance of the delicate repair eye cream, for example, in one embodiment, the instant wrinkle removal essence is an alteromonas ferment product extract, the active ingredient of the alteromonas ferment product extract is extracellular polysaccharide which consists of galactose, galacturonic acid, glucose, glucuronic acid and mannose, and the wrinkle smoothing performance can be quickly filled and the skin can be tightly compacted; the skin-care eye cream has the effects of remarkably promoting the synthesis of collagen, elastin and hyaluronic acid, reducing wrinkles from the interior of skin, resisting aging, tightening collagen lattices, and enhancing the ability of the delicate eye cream to resist free radicals, smoothing wrinkles, glowing and restoring elasticity, and the skin is smooth, fine and compact. The starfish regeneration and repair factor is rich in four different starfish saponins, small peptides, free amino acids and mineral substances. The eye cream is a very strong anti-aging active ingredient, is a natural substitute of retinol, has the performances of no color, no odor, no irritation and no side effect, and can promote the skin to renew and regenerate, repair the skin barrier function and promote wound healing, so that the delicate repairing eye cream has the performances of resisting wrinkles, enhancing the skin elasticity, compacting the skin and promoting the skin hydration. The centella asiatica extract has the effects of remarkably promoting the synthesis of collagen, elastin and hyaluronic acid, reducing wrinkles from the inside of the skin and resisting aging; accelerate the healing of the skin, thereby reconstructing the damaged skin. In one embodiment, the centella asiatica extract is asiaticoside, madecassoside, asiatic acid and madecassic acid, and can further improve the wrinkle reducing and anti-aging performance of the fine repair eye cream. The asiatic centella polypeptide is a concentrated secretion of totipotent cells from the asiatic centella petioles, the secretion is rich in plant polypeptide, can reverse the skin aging process, induce cell proliferation, stimulate cell detoxification, induce cell protection DNA and cell remodeling, and the adoption of the asiatic centella polypeptide can enable the delicate repair eye cream to have the performances of improving skin elasticity and compactness, reversing skin aging and recovering young appearance. Metabolites of the yeast lysate of the binary split yeast include small organic acids (lactic acid, acetic acid, propionic acid, butyric acid, etc.), vitamins (B1, B2, B6, B12), amino acids (alanine, valine, aspartic acid, threonine); the broken products comprise cell secretion (polysaccharide complex, small molecule peptide), cell content (nucleic acid, protein, cytoplasm fragment), cell rigid structure (teichoic acid, peptidoglycan, cell membrane lipid) and are rich in bifidobacterium prebiotics, so that the delicate repair eye cream has the performance of repairing damaged skin barrier, improving microbial environment on the surface of skin, resisting free radical and promoting the proliferation of collagen and fibroblasts. The ceramide liposome can regulate the water loss of skin, improve the water content of skin and repair the performance of damaged skin barrier, so that the delicate repair eye cream can improve the barrier function and the autoimmune capacity of skin, improve rough and dry skin and improve the elasticity of skin. The anti-allergic active peptide is an active substance in the fine repair eye cream, and is effective in slowing down aging and anti-allergy, and further, in one embodiment, the anti-allergic active peptide is oligopeptide-29, so that the fine repair eye cream has enhanced anti-free radical resistance, anti-allergy and anti-aging properties, and further, the oligopeptide-29 is manufactured by the company CAREGEN korea. Thus, the active substances of the components in the phase D can effectively improve the ability of the delicate repair eye cream to resist free radicals, and also enables the delicate repair eye cream to effectively improve 7 major problems of skin around eyes: fine lines, wrinkles, laxity, under-eye bags, puffiness, dark under-eye circles and dryness problems.
It is understood that phenoxyethanol and menthone generally act as preservatives in cosmetics and skin care products, and can improve the storage properties of the delicate eye cream. The essence can remove unpleasant odor in the original product, has exciting and tranquilizing effects, and improves the use feeling of the delicate repair eye cream. Thus, the storage stability and the use feeling of the fine repair eye cream can be improved by using the components of the phase E.
The delicate repair eye cream of another embodiment comprises the following components in parts by mass:
phase A: 0.1 to 0.6 portion of polyglycerol-10 stearate, 1.0 to 4.0 portions of polydimethylsiloxane, 0.1 to 1.0 portion of polymethylsilsesquioxane, 0.8 to 4.0 portions of hydrogenated coconut oil glyceride, 0.15 to 1.8 portions of phytosterol oleate and 0.2 to 1.7 portions of tocopheryl acetate;
phase B: 52.0 to 90.0 portions of deionized water, 3.0 to 11.0 portions of glycerol, 0.2 to 0.6 portion of hydrogenated lecithin, 0.4 to 1.0 portion of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2 to 0.5 portion of carbomer, 0.3 to 0.7 portion of PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether and 0.2 to 0.8 portion of inulin lauryl carbamate;
and C phase: 0.05 to 0.3 portion of polyglutamic acid and 0.2 to 1.0 portion of cyclomethicone/dimethiconol mixture;
phase D: 0.16 to 0.35 portion of triethanolamine;
phase E: 1.5 to 3.0 parts of caffeine, 0.2 to 1.7 parts of glucosyl hesperidin, 1.0 to 4.0 parts of bitter orange flower extract, 2.5 to 7.0 parts of inositol, 1.5 to 4.0 parts of oat glucan, 1.2 to 3.0 parts of undaria pinnatifida extract, 0.6 to 2.0 parts of instant wrinkle removing essence, 1.1 to 2.0 parts of Starfish regeneration and repair factor, 0.8 to 2.0 parts of centella asiatica extract, 0.4 to 2.0 parts of centella asiatica polypeptide, 0.4 to 2.5 parts of yeast bifida fermentation lysate and 0.3 to 1.1 parts of anti-allergy active peptide;
and (3) phase F: 0.3 to 0.6 portion of phenoxyethanol, 0.1 to 0.4 portion of fragrant fresh ketone and 0.01 to 0.07 portion of essence.
By further optimizing the proportion of the components of the delicate repairing eye cream, the repairing performance of the delicate repairing eye cream can be further enhanced, and the problem of skin around eyes can be better improved.
The delicate repair eye cream of another embodiment comprises the following components in parts by mass:
phase A: 0.3 part of polyglycerol-10 stearate, 2.0 parts of polydimethylsiloxane, 0.5 part of polymethylsilsesquioxane, 3.0 parts of hydrogenated coconut oil glycerides, 0.5 part of phytosterol oleate and 0.5 part of tocopherol acetate;
phase B: 58.84 parts of deionized water, 10 parts of glycerol, 0.3 part of hydrogenated lecithin, 0.8 part of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.3 part of carbomer, 0.5 part of PEG-240/HDI copolymer bis-decyltetradecylpolyether-20 ether and 0.3 part of inulin lauryl carbamate;
and C phase: 0.1 part of polyglutamic acid, and 0.5 part of cyclomethicone/dimethiconol mixture;
phase D: 0.25 part of triethanolamine;
phase E: 2.0 parts of caffeine, 0.5 part of glucosyl hesperidin, 2.0 parts of bitter orange flower extract, 5.0 parts of inositol, 2.0 parts of oat glucan, 2.0 parts of undaria pinnatifida extract, 1.0 part of instant wrinkle removal essence, 1.6 parts of starfish regeneration and repair factor, 1.0 part of centella asiatica extract, 1.0 part of centella asiatica polypeptide, 2.0 parts of yeast schizolysis product and 0.5 part of anti-allergy active peptide;
and (3) phase F: 0.5 part of phenoxyethanol, 0.2 part of fragrant fresh ketone and 0.01 part of essence.
By further optimizing the proportion of the components of the delicate repairing eye cream, the repairing performance of the delicate repairing eye cream can be further optimized, and the problem of skin around eyes can be better improved.
Referring to fig. 1, a method for preparing an delicate eye cream according to an embodiment includes the following steps:
and S110, cleaning and disinfecting the equipment for standby.
In order to ensure the quality of the prepared delicate repair eye cream and prevent the fine repair eye cream from being infected by pollutants, the equipment used in the preparation needs to be cleaned and disinfected firstly.
S120, adding polyglycerol-10 stearate, polydimethylsiloxane, polymethylsilsesquioxane and hydrogenated coconut oil glyceride into an oil phase pot, carrying out first heating and stirring operation, keeping constant temperature until the materials are completely dissolved, then adding phytosterol oleate and tocopherol acetate, and uniformly mixing to obtain an oil phase mixture, wherein the mass ratio of the polyglycerol-10 stearate to the polydimethylsiloxane to the polymethylsilsesquioxane to the hydrogenated coconut oil glyceride to the phytosterol oleate to the tocopherol acetate is (0.05-0.8): (0.5-5.0): (0.05-2.0): (0.5-5.0): (0.05-2.0): (0.05-2.0).
The preparation method comprises the steps of adding polyglycerol-10 stearate, polydimethylsiloxane, polymethylsilsesquioxane and hydrogenated coconut oil glycerides into an oil phase pot, carrying out first heating stirring operation, accelerating dissolution and uniform mixing of all components under a high-temperature condition, then keeping a constant temperature condition until the materials are completely dissolved, adding phytosterol oleate and tocopherol acetate, mixing uniformly to obtain an oil phase mixture, and in addition, controlling the proportion of all the components to be favorable for preparing the delicate repair eye cream with better repair performance.
In one embodiment, the temperature of the first heating and stirring operation is 70 ℃ to 75 ℃. By raising the temperature to 70-75 ℃, the dissolution and the uniform dispersion of polyglycerol-10 stearate, polydimethylsiloxane, polymethylsilsesquioxane and hydrogenated coconut oil glyceride can be promoted.
S130, adding deionized water, glycerol, hydrogenated lecithin, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, carbomer, PEG-240/HDI copolymer bis-decyltetradecyltetradecylpolyether-20 ether and inulin lauryl carbamate into an emulsifying pot, carrying out second heating and stirring operation, keeping the constant temperature for 9-12 minutes, carrying out first homogenization operation, adding a mixture of polyglutamic acid and cyclopolydimethylsiloxane/dimethiconol and the oil phase mixture, stirring, carrying out second homogenization operation under a vacuum condition, carrying out defoaming operation, adding triethanolamine, and stirring uniformly, wherein the deionized water, the glycerol, the hydrogenated lecithin, the hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, the carbomer, the HDI copolymer and the like, The mass ratio of PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether, the inulin lauryl carbamate, the polyglutamic acid, the cyclopolydimethylsiloxane/dimethiconol mixture, the oil phase mixture and the triethanolamine is (50.0-100.0): (1.0-11.0): (0.1-0.8): (0.1-1.0): (0.2-0.6): (0.1-0.8): (0.1-1.0): (0.01-0.5): (0.1-2.0): (1.2-16.8): (0.15-0.55).
Deionized water, glycerol, hydrogenated lecithin, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, carbomer, PEG-240/HDI copolymer bis-decyltetradecyltetradecylpolyether-20 ether and inulin lauryl carbamate are added into an emulsifying pot, after a second heating and stirring operation, the components can be better dissolved and dispersed under the high temperature condition, in one embodiment, the temperature of the second heating and stirring operation is 80-85 ℃, so that the dissolution and emulsification reaction of the components can be further promoted, then the constant temperature is kept for 9-12 minutes to fully dissolve and emulsify the components, then the first homogenizing operation is carried out to fully mix and uniformly disperse the components, and then a polyglutamic acid and cyclomethicone/dimethiconol mixture and the oil phase mixture are added for stirring, and (3) carrying out second homogenization operation under the vacuum condition, then carrying out defoaming operation, adding triethanolamine and uniformly stirring. It can be understood that under the vacuum condition, bubbles generated in the stirring and emulsifying process of each component can be eliminated, some generated volatile gas is pumped out, and then defoaming operation is carried out, so that the bubbles in the emulsifying pot can be further eliminated, the quality and the repairing performance of the delicate repairing eye cream are improved, and in addition, the preparation of the delicate repairing eye cream with better repairing performance is facilitated by controlling the proportion of each component.
S140, after the first cooling operation is carried out, sequentially adding caffeine, glucosyl hesperidin, a bitter orange flower extract, inositol, oat glucan, an undaria pinnatifida extract, an instant wrinkle removing essence, a starfish regeneration repair factor, an centella asiatica extract, centella asiatica polypeptide, a secondary fission yeast fermentation product lysate and an anti-allergy active peptide, and carrying out a third stirring operation, wherein the third stirring operation is carried out at a constant temperature until the materials are completely dissolved, wherein the caffeine, the glucosyl hesperidin, the bitter orange flower extract, the inositol, the oat glucan, the undaria pinnatifida extract, the instant wrinkle removing essence, the starfish regeneration repair factor, the centella asiatica extract, the centella asiatica polypeptide, the secondary fission yeast fermentation product lysate and the anti-allergy active peptide are mixed according to a mass ratio of (0.5-5.0): (0.1-2.0): (0.0-5.0): (0.5-10.0): (0.5-5.0): (0.0-4.0): (0.0-3.0): (0.1-3.0): (0.1-3.0): (0.1-3.0): (0.1-3.0): (0.1 to 1.5).
The temperature in the reaction system can be reduced by carrying out the first temperature reduction operation, the damage to each component which is easy to reduce the activity or even lose the activity due to high temperature is avoided, then sequentially adding caffeine, glucosyl hesperidin, bitter orange flower extract, inositol, oat glucan, Undaria pinnatifida extract, instant wrinkle removing essence, starfish regeneration and repair factor, centella asiatica extract, centella asiatica polypeptide, schizosaccharomyces cerevisiae fermentation product lysate and anti-allergy active peptide, carrying out third stirring operation, keeping constant temperature until the materials are completely dissolved, for example, in one embodiment, the first temperature reduction operation is carried out, the temperature is reduced to 52-55 ℃, the activity of each component can be maintained to be damaged due to high temperature, the energy consumption can be reduced, in addition, by controlling the proportion of the components, the delicate repair eye cream with better repair performance can be prepared.
S150, after the second cooling operation is carried out, sequentially adding the pre-dissolved phenoxyethanol, the pre-dissolved menthone and the essence, and uniformly stirring to obtain the repair eye cream precursor.
And (3) further reducing the temperature by carrying out a second temperature reduction operation, for example, in one embodiment, reducing the temperature to 42-44 ℃, sequentially adding the dissolved phenoxyethanol, the parfenthiuron and the essence, uniformly mixing, reducing the energy consumption while ensuring that the performances of the components are not damaged, and obtaining the repairing eye cream precursor after uniform stirring.
And S160, after the third cooling operation is carried out, carrying out detection operation on the repair eye cream precursor, filtering and discharging after the repair eye cream precursor is qualified, and thus obtaining the delicate repair eye cream.
And after the components are mixed and homogenized, performing a third cooling operation to further reduce the temperature of the repair eye cream precursor, maintaining the stability of the repair eye cream precursor, performing detection operation, filtering and discharging after the repair eye cream precursor is qualified, and thus obtaining the delicate repair eye cream. For example, in one embodiment, after the third temperature reduction operation, the temperature is controlled to 38 ℃ to 39 ℃, so that the activity of the repair eye cream precursor can be kept from being damaged, and the stability can be improved.
The following is a detailed description of the embodiments.
Example 1
Cleaning and sterilizing equipment for later use;
adding 0.3kg of polyglycerol-10 stearate, 2.0kg of polydimethylsiloxane, 0.5kg of polymethylsilsesquioxane and 3.0kg of hydrogenated coconut oil glyceride into an oil phase pot, carrying out first heating and stirring operation at the temperature of 70 ℃, keeping constant temperature until the materials are completely dissolved, adding 0.5kg of phytosterol oleate and 0.8kg of tocopherol acetate, and uniformly mixing to obtain an oil phase mixture;
adding 59.24kg of deionized water, 10kg of glycerol, 0.3kg of hydrogenated lecithin, 0.8kg of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.3kg of carbomer, 0.5kg of PEG-240/HDI copolymer bis-decyltetradecanoylpolyether-20 ether and 0.3kg of inulin lauryl carbamate into an emulsifying pot, carrying out second heating and stirring operation at the temperature of 80 ℃, keeping the temperature for 9 minutes at constant temperature, carrying out first homogenization operation, adding 0.2kg of polyglutamic acid and 1.0kg of cyclomethicone/dimethiconol mixture and the oil phase mixture, stirring for 1 minute, carrying out second homogenization operation for 10 minutes under the vacuum condition, then carrying out defoaming operation, adding 0.25kg of triethanolamine and stirring uniformly;
after the first cooling operation is carried out, the temperature is reduced to 55 ℃, 2.0kg of caffeine, 0.8kg of glucosyl hesperidin, 1.0kg of bitter orange flower extract, 5.0kg of inositol, 2.0kg of oat glucan, 2.0kg of undaria pinnatifida extract, 1.0kg of instant wrinkle removal essence, 1.6kg of starfish regeneration and repair factor, 0.5kg of centella asiatica extract, 1.5kg of centella asiatica polypeptide, 1.5kg of schizosaccharomyces cerevisiae fermentation product lysate and 0.5kg of anti-allergy active peptide are sequentially added, and the third stirring operation is carried out and the constant temperature is kept until the materials are completely dissolved;
after the second cooling operation is carried out, the temperature is reduced to 44 ℃, 0.5kg of phenoxy ethanol, 0.2kg of jasminon and 0.01kg of essence which are dissolved in advance are sequentially added, and the mixture is uniformly stirred to obtain a repair eye cream precursor;
and after the third cooling operation is carried out, the temperature is reduced to 39 ℃, the repairing eye cream precursor is subjected to detection operation, and filtered and discharged after being qualified, so that the delicate repairing eye cream in the embodiment 1 is obtained.
Example 2
Cleaning and sterilizing equipment for later use;
adding 0.3kg of polyglycerol-10 stearate, 2.0kg of polydimethylsiloxane, 0.5kg of polymethylsilsesquioxane and 3.0kg of hydrogenated coconut oil glyceride into an oil phase pot, carrying out first heating and stirring operation at the temperature of 70 ℃, keeping constant temperature until the materials are completely dissolved, adding 0.5kg of phytosterol oleate and 0.5kg of tocopherol acetate, and uniformly mixing to obtain an oil phase mixture;
58.84kg of deionized water, 10kg of glycerol, 0.3kg of hydrogenated lecithin, 0.8kg of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.3kg of carbomer, 0.5kg of PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether and 0.3kg of inulin lauryl carbamate are added into an emulsifying pot, the mixture is kept at a constant temperature for 9 minutes after a second heating and stirring operation is carried out at the temperature of 80 ℃, a first homogenizing operation is carried out, 0.2kg of polyglutamic acid and 0.5kg of cyclomethicone/dimethiconol mixture and the oil phase mixture are added and stirred for 1 minute, a second homogenizing operation is carried out for 10 minutes under the vacuum condition, and then 0.25kg of triethanolamine is added and stirred uniformly after defoaming operation is carried out again;
after the first cooling operation is carried out, the temperature is reduced to 55 ℃, 2.0kg of caffeine, 0.5kg of glucosyl hesperidin, 2.0kg of bitter orange flower extract, 5.0kg of inositol, 2.0kg of oat glucan, 2.0kg of undaria pinnatifida extract, 1.0kg of instant wrinkle removal essence, 1.6kg of starfish regeneration and repair factor, 1.0kg of centella asiatica extract, 1.0kg of centella asiatica polypeptide, 2.0kg of lysate of yeast bifida fermentation product and 0.5kg of anti-allergy active peptide are sequentially added, and the third stirring operation is carried out and the constant temperature is kept until the materials are completely dissolved;
after the second cooling operation is carried out, the temperature is reduced to 44 ℃, 0.5kg of phenoxy ethanol, 0.2kg of jasminon and 0.01kg of essence which are dissolved in advance are sequentially added, and the mixture is uniformly stirred to obtain a repair eye cream precursor;
and after the third cooling operation, cooling the temperature to 39 ℃, detecting the repair eye cream precursor, filtering and discharging after the repair eye cream precursor is qualified, and thus obtaining the delicate repair eye cream of the embodiment 2.
The following are the results of performance tests on the skin hydration promoting cosmetic:
1. skin hydration
Testing the population: 50 persons, female testers of 40-65 years old, used the fine conditioning eye cream prepared in example 2 of the present invention 2 times a day in the morning and evening, and the moisturizing effect was evaluated by measurement with a skin cutin tester. After 28 days, the hydration of the facial skin is increased by 13.2%, and the skin is healthier and more moist.
2. Anti-aging effect
Testing the population: 50 persons, female testers aged 40-65 years, tested 28 days, using the fine repair eye cream prepared in example 2 of the present invention 2 times a day, morning and evening.
Testing parameters: wrinkle depth, skin firmness, skin elasticity. The results are shown in table 1 below after 28 consecutive days using the skin elasticity tester MAP 580:
skin Properties Compared with the control group without the delicate repair eye cream
Degree of skin firmness Increase by 16.9 percent
Elasticity of skin Increase by 7.8 percent
Depth of wrinkles The reduction is 12.3 percent
TABLE 1
3. Edema and dark circles
Testing the population: 50 persons, female testers aged 40-65 years, tested 28 days, using the fine repair eye cream prepared in example 2 of the present invention 2 times a day, morning and evening.
After 3 hours, 86% of the subjects showed a marked increase in skin circulation, indicating the elimination of venous stasis.
After 14 days, 88% of testers fed back with effect, 12% of testers fed back with no effect, and 62% of testers fed back with good effect.
After 28 days, the skin circulation was reduced and returned to normal levels in 74% of the subjects, indicating that the edema had been gradually relieved.
4. Eye bag
Testing the population: 50 persons, female testers aged 40-65 years, tested for 56 days, and used the fine repair eye cream prepared in example 2 of the present invention 2 times a day in the morning and evening.
After 56 days, 66% of testers fed back the pouch with an effect, 34% of testers fed back the pouch with little change, and 42% of testers fed back the pouch with a better effect, and the pouch is obviously reduced.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.

Claims (8)

1. The delicate repair eye cream is characterized by being prepared from the following components in parts by mass:
phase A: 0.05 to 0.8 portion of polyglycerol-10 stearate, 0.5 to 5.0 portions of polydimethylsiloxane, 0.05 to 2.0 portions of polymethylsilsesquioxane, 0.5 to 5.0 portions of hydrogenated coconut oil glyceride, 0.05 to 2.0 portions of phytosterol oleate and 0.05 to 2.0 portions of tocopheryl acetate;
phase B: 50.0 to 100.0 portions of deionized water, 1.0 to 11.0 portions of glycerol, 0.1 to 0.8 portion of hydrogenated lecithin, 0.1 to 1.0 portion of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2 to 0.6 portion of carbomer, 0.1 to 0.8 portion of PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether and 0.1 to 1.0 portion of inulin lauryl carbamate;
and C phase: 0.01 to 0.5 portion of polyglutamic acid and 0.1 to 2.0 portions of cyclomethicone/dimethiconol mixture;
phase D: 0.15 to 0.55 portion of triethanolamine;
phase E: 0.5 to 5.0 portions of caffeine, 0.1 to 2.0 portions of glucosyl hesperidin, 0.0 to 5.0 portions of bitter orange flower extract, 0.5 to 10.0 portions of inositol, 0.5 to 5.0 portions of oat glucan, 0.0 to 4.0 portions of undaria pinnatifida extract, 0.0 to 3.0 portions of instant wrinkle removing essence, 0.1 to 3.0 portions of Starfish regeneration repair factor, 0.1 to 3.0 portions of centella asiatica extract, 0.1 to 3.0 portions of centella asiatica polypeptide, 0.1 to 3.0 portions of yeast bifida fermentation lysate and 0.1 to 1.5 portions of anti-allergy active peptide;
and (3) phase F: 0.2 to 0.8 portion of phenoxyethanol, 0.1 to 0.5 portion of fragrant fresh ketone and 0.01 to 0.1 portion of essence;
the centella asiatica extract is asiaticoside, madecassoside, asiatic acid and madecassic acid;
the instant wrinkle removing essence is an alteromonas fermentation product extract.
2. The delicate repair eye cream according to claim 1, which is prepared from the following components in parts by mass:
phase A: 0.1 to 0.6 portion of polyglycerol-10 stearate, 1.0 to 4.0 portions of polydimethylsiloxane, 0.1 to 1.0 portion of polymethylsilsesquioxane, 0.8 to 4.0 portions of hydrogenated coconut oil glyceride, 0.15 to 1.8 portions of phytosterol oleate and 0.2 to 1.7 portions of tocopheryl acetate;
phase B: 52.0 to 90.0 portions of deionized water, 3.0 to 11.0 portions of glycerol, 0.2 to 0.6 portion of hydrogenated lecithin, 0.4 to 1.0 portion of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2 to 0.5 portion of carbomer, 0.3 to 0.7 portion of PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether and 0.2 to 0.8 portion of inulin lauryl carbamate;
and C phase: 0.05 to 0.3 portion of polyglutamic acid and 0.2 to 1.0 portion of cyclomethicone/dimethiconol mixture;
phase D: 0.16 to 0.35 portion of triethanolamine;
phase E: 1.5 to 3.0 parts of caffeine, 0.2 to 1.7 parts of glucosyl hesperidin, 1.0 to 4.0 parts of bitter orange flower extract, 2.5 to 7.0 parts of inositol, 1.5 to 4.0 parts of oat glucan, 1.2 to 3.0 parts of undaria pinnatifida extract, 0.6 to 2.0 parts of instant wrinkle removing essence, 1.1 to 2.0 parts of Starfish regeneration and repair factor, 0.8 to 2.0 parts of centella asiatica extract, 0.4 to 2.0 parts of centella asiatica polypeptide, 0.4 to 2.5 parts of yeast bifida fermentation lysate and 0.3 to 1.1 parts of anti-allergy active peptide;
and (3) phase F: 0.3 to 0.6 portion of phenoxyethanol, 0.1 to 0.4 portion of fragrant fresh ketone and 0.01 to 0.07 portion of essence.
3. The delicate repair eye cream according to claim 2, which is prepared from the following components in parts by mass:
phase A: 0.3 part of polyglycerol-10 stearate, 2.0 parts of polydimethylsiloxane, 0.5 part of polymethylsilsesquioxane, 3.0 parts of hydrogenated coconut oil glycerides, 0.5 part of phytosterol oleate and 0.5 part of tocopherol acetate;
phase B: 58.84 parts of deionized water, 10 parts of glycerol, 0.3 part of hydrogenated lecithin, 0.8 part of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.3 part of carbomer, 0.5 part of PEG-240/HDI copolymer bis-decyltetradecylpolyether-20 ether and 0.3 part of inulin lauryl carbamate;
and C phase: 0.1 part of polyglutamic acid, and 0.5 part of cyclomethicone/dimethiconol mixture;
phase D: 0.25 part of triethanolamine;
phase E: 2.0 parts of caffeine, 0.5 part of glucosyl hesperidin, 2.0 parts of bitter orange flower extract, 5.0 parts of inositol, 2.0 parts of oat glucan, 2.0 parts of undaria pinnatifida extract, 1.0 part of instant wrinkle removal essence, 1.6 parts of starfish regeneration and repair factor, 1.0 part of centella asiatica extract, 1.0 part of centella asiatica polypeptide, 2.0 parts of yeast schizolysis product and 0.5 part of anti-allergy active peptide;
and (3) phase F: 0.5 part of phenoxyethanol, 0.2 part of fragrant fresh ketone and 0.01 part of essence.
4. The preparation method of the delicate repair eye cream is characterized by comprising the following steps:
cleaning and sterilizing equipment for later use;
adding polyglycerol-10 stearate, polydimethylsiloxane, polymethylsilsesquioxane and hydrogenated coconut oil glyceride into an oil phase pot, carrying out first heating and stirring operation, keeping constant temperature until the materials are completely dissolved, then adding phytosterol oleate and tocopherol acetate, and uniformly mixing to obtain an oil phase mixture, wherein the mass ratio of the polyglycerol-10 stearate to the polydimethylsiloxane to the polymethylsilsesquioxane to the hydrogenated coconut oil glyceride to the phytosterol oleate to the tocopherol acetate is (0.05-0.8): (0.5-5.0): (0.05-2.0): (0.5-5.0): (0.05-2.0): (0.05-2.0);
adding deionized water, glycerol, hydrogenated lecithin, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, carbomer, PEG-240/HDI copolymer bis-decyltetradecyltetradecylpolyether-20 ether and inulin lauryl carbamate into an emulsifying pot, carrying out second heating and stirring operation, keeping the constant temperature for 9-12 minutes, carrying out first homogenization operation, adding a mixture of polyglutamic acid and cyclopolydimethylsiloxane/dimethiconol and the oil phase mixture, stirring, carrying out second homogenization operation under a vacuum condition, then carrying out defoaming operation, adding triethanolamine and uniformly stirring, wherein the deionized water, the glycerol, the hydrogenated lecithin, the hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, the carbomer, the PEG-240/HDI copolymer bis-decyltetradecyltetradecyltetradecyltetradecyltetradecyltetradecyltolyether-20 ether, the carbomer, the PEG-240/HDI copolymer, the inulin lauryl taurate copolymer, the ethylene glycol and the HDI copolymer, The inulin lauryl carbamate, the polyglutamic acid, the cyclopolydimethylsiloxane/dimethiconol mixture, the oil phase mixture and the triethanolamine are in a mass ratio of (50.0-100.0): (1.0-11.0): (0.1-0.8): (0.1-1.0): (0.2-0.6): (0.1-0.8): (0.1-1.0): (0.01-0.5): (0.1-2.0): (1.2-16.8): (0.15 to 0.55);
after the first cooling operation is carried out, sequentially adding caffeine, glucosyl hesperidin, a bitter orange flower extract, inositol, oat glucan, an undaria pinnatifida extract, instant wrinkle removing essence, a starfish regeneration repair factor, an centella asiatica extract, centella asiatica polypeptide, a schizosaccharomyces cerevisiae fermentation product lysate and an anti-allergy active peptide, carrying out a third stirring operation, and keeping at a constant temperature until the materials are completely dissolved, wherein the caffeine, the glucosyl hesperidin, the bitter orange flower extract, the inositol, the oat glucan, the undaria pinnatifida extract, the instant wrinkle removing essence, the starfish regeneration repair factor, the centella asiatica extract, the centella asiatica polypeptide, the schizosaccharomyces cerevisiae fermentation product lysate and the anti-allergy active peptide are mixed according to a mass ratio of (0.5-5.0): (0.1-2.0): (0.0-5.0): (0.5-10.0): (0.5-5.0): (0.0-4.0): (0.0-3.0): (0.1-3.0): (0.1-3.0): (0.1-3.0): (0.1-3.0): (0.1 to 1.5);
after the second cooling operation is carried out, sequentially adding the pre-dissolved phenoxyethanol, the pre-dissolved menthone and the essence, and uniformly stirring to obtain a repair eye cream precursor;
and after the third cooling operation is carried out, the repairing eye cream precursor is subjected to detection operation, and filtered and discharged after being qualified, so that the delicate repairing eye cream is obtained.
5. The method of preparing the fine repair eye cream according to claim 4, wherein the temperature of the first heating and stirring operation is 70 to 75 ℃.
6. The method for preparing the delicate repair eye cream according to claim 4, wherein the temperature of the second heating and stirring operation is 80 to 85 ℃.
7. The method for preparing the delicate repair eye cream according to claim 4, wherein the temperature is controlled to 42 ℃ to 44 ℃ after the second cooling operation.
8. The method for preparing the delicate repair eye cream according to claim 4, wherein the temperature is controlled to 38 ℃ to 39 ℃ after the third cooling operation.
CN201811633506.0A 2018-12-29 2018-12-29 Delicate repair eye cream and preparation method thereof Active CN109453089B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811633506.0A CN109453089B (en) 2018-12-29 2018-12-29 Delicate repair eye cream and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811633506.0A CN109453089B (en) 2018-12-29 2018-12-29 Delicate repair eye cream and preparation method thereof

Publications (2)

Publication Number Publication Date
CN109453089A CN109453089A (en) 2019-03-12
CN109453089B true CN109453089B (en) 2021-11-12

Family

ID=65615634

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811633506.0A Active CN109453089B (en) 2018-12-29 2018-12-29 Delicate repair eye cream and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109453089B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111939114A (en) * 2019-05-14 2020-11-17 西安博和医疗科技有限公司 Eye care composition
CN110638707A (en) * 2019-10-29 2020-01-03 浙江英树生物科技有限公司 Eye care cream and preparation method thereof
CN110897989B (en) * 2019-12-24 2021-11-26 广州蜜妆生物科技有限公司 Sensitive skin repair emulsion
CN111658557A (en) * 2020-06-22 2020-09-15 泉后(广州)生物科技研究院有限公司 Nano-structure liposome capable of eliminating eye bags immediately and preparation method and application thereof
CN112353725A (en) * 2020-11-19 2021-02-12 广州领衔生物科技有限公司 Efficacy composition in eye cream, eye cream and preparation method thereof
CN113018223A (en) * 2021-03-24 2021-06-25 湖北省麦诗特生物科技有限公司 Eye tightening fatigue immunity eye cream composition containing coral algae compound and preparation method thereof
CN113679646B (en) * 2021-08-09 2023-07-21 深圳市护家科技有限公司 Caffeine tightening and repairing eye cream and preparation method thereof
CN113813205A (en) * 2021-09-10 2021-12-21 仙婷(广州)科技研发有限公司 Multifunctional eye care composition and application thereof
CN113876656A (en) * 2021-10-29 2022-01-04 湖北省麦诗特生物科技有限公司 Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof
CN114028245B (en) * 2021-11-29 2024-03-26 浙江宜格企业管理集团有限公司 Mild exfoliating composition and preparation method thereof
CN114796050A (en) * 2022-04-27 2022-07-29 蓓悠清(广东)健康科技有限公司 Efficient moisturizing and relieving gel mask and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102166181A (en) * 2011-04-22 2011-08-31 广州舒泰生物技术有限公司 Multifunctional eye cream capable of dispelling wrinkles, eye puffiness and black eye
KR20120017987A (en) * 2010-08-20 2012-02-29 (주)라이프앤진 Cosmetic composition for removal the wrinkles at the corners of one's eyes
CN105147590A (en) * 2015-10-19 2015-12-16 广州科玛生物科技有限公司 Anti-wrinkle eye cream and preparation method thereof
CN106727002A (en) * 2016-12-30 2017-05-31 广州市中通生化制品有限公司 A kind of eye cream of multi-efficiency and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120017987A (en) * 2010-08-20 2012-02-29 (주)라이프앤진 Cosmetic composition for removal the wrinkles at the corners of one's eyes
CN102166181A (en) * 2011-04-22 2011-08-31 广州舒泰生物技术有限公司 Multifunctional eye cream capable of dispelling wrinkles, eye puffiness and black eye
CN105147590A (en) * 2015-10-19 2015-12-16 广州科玛生物科技有限公司 Anti-wrinkle eye cream and preparation method thereof
CN106727002A (en) * 2016-12-30 2017-05-31 广州市中通生化制品有限公司 A kind of eye cream of multi-efficiency and preparation method thereof

Also Published As

Publication number Publication date
CN109453089A (en) 2019-03-12

Similar Documents

Publication Publication Date Title
CN109453089B (en) Delicate repair eye cream and preparation method thereof
JP4099173B2 (en) Cosmetic or dermopharmaceutical composition comprising kombucha
CN107198675B (en) Double-layer essence with repairing and anti-aging effects and preparation method thereof
CN109431964A (en) Assign maintenance essence cream living and preparation method thereof in flesh source
CN109528524A (en) Mousse frost and preparation method thereof
CN106176567B (en) A kind of double-deck facial treatment milk and preparation method thereof
CN105902408B (en) Cosmetic composition containing brown alga and red algae essence
CN104055716B (en) Vitamin repairs elite
CN111110584A (en) Skin care composition with moisturizing and anti-aging effects and preparation method thereof
CN112137951A (en) Silicone-oil-free transparent amino acid shampoo capable of strengthening hair and repairing scalp barrier and preparation method thereof
CN112353725A (en) Efficacy composition in eye cream, eye cream and preparation method thereof
CN111603433A (en) Mild washing and caring product for infants and preparation method thereof
CN108888539B (en) Organic skin-care matrix, preparation method and application thereof, and organic cosmetic
CN114159335A (en) Cubilose acid moisturizing and repairing nano composition, preparation method thereof and cosmetic
CN102198060B (en) Composition and cosmetic for slowing down skin aging
CN109431854A (en) A kind of bFGF acne hole maintenance freeze-dried powder preparation and preparation method thereof
CN107468610A (en) A kind of extraction product of rice bran shell and its application in facial-care
WO2023236326A1 (en) Method for preparing hyaluronic acid-collagen composite cross-linked microspheres for face filling
CN111631965A (en) Plant-derived facial mask with cleaning and makeup removing functions
CN110693778A (en) Face cream and production process thereof
CN111265454B (en) Moisture-preserving and water-replenishing anti-aging cosmetic composition
CN111568827A (en) Moisturizing and makeup removing mousse
CN111358710A (en) Moisture-preserving and soothing donkey-hide gelatin face cream and preparation method thereof
CN105919886A (en) Quick-acting wrinkle repairing emulsion and preparation method thereof
CN113730289B (en) Eye and lip care composition with multiple repairing effects and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant